Duygu Duzgun

Duygu Duzgun is a researcher at the University of Exeter's Medical School, holding an MSc in Genomic Medicine (2021) supervised by Professor Sebastian Oltean. Her work bridges molecular pathology and translational cancer research with institutional affiliation at St Luke's Campus, Exeter.

Her academic credentials include:

• B.Sc. in Bioengineering from Gaziosmanpaa University, Tokat, Turkey
• M.Sc. in Bioengineering from Gaziosmanpaa University, Tokat, Turkey
• M.Sc. in Genomic Medicine from the University of Exeter, Exeter, UK

Duzgun's research centers on alternative splicing mechanisms in oncology, particularly investigating FGFR2 and SRPK1 roles in prostate cancer progression and therapy resistance. Her genomic medicine expertise extends to recombinant DNA technology and therapeutic strategy development, with significant contributions to understanding epithelial-mesenchymal transitions and tumor chemoresistance pathways. Early work involved bioreactor-based protein engineering, demonstrating technical proficiency in recombinant systems.

Publication analysis (2019-2025) reveals an evolving research trajectory from protein production engineering to molecular oncology, with recent work exclusively focused on splicing dysregulation in therapy-resistant cancers. Her 2024-2025 publications establish a cohesive theme around splicing factors as therapeutic targets, particularly emphasizing SRPK1's role across multiple cancer types while maintaining prostate cancer as a key model system.

No scientific awards were documented in the source materials.

Student supervision and grant activities were not referenced in available information.

Research team affiliations and laboratory infrastructure details were not specified in the provided texts.